Cutting the cure.
Federal health leadership cuts mRNA research funding at the moment mRNA just cured cancer.
Source article: Moderna's personalized cancer vaccine clears phase 3 melanoma trial.
Column metadata
- Published
- Pen name
- Editorial Board
- Topic tags
- biotechnology, health treatment and procedure, medical research, science and technology, health
- Storylines
- moderna-and-merck-s-personalized-cancer-vaccine-development
- Primary entities
- Moderna, Merck, Stéphane Bancel, Stephen Hoge, Drew Weissman, Roger Perlmutter, Robert F. Kennedy Jr., Greg Byrne, Patrick Degorce, Ira Mellman, Food and Drug Administration, Keytruda
- Themes
- Oncology drug development, mRNA technology, Phase 3 clinical trial results, Personalized cancer treatment, Biotech industry
- Floor values engaged
- human_life_and_dignity, Truthfulness, Accountability of power